Thermo Fisher Scientific
Discovery proteomics, translational research, and precision medicine perform global proteome profiling of large sample sets to identify putative protein and/or peptide biomarkers across different biological conditions. In this webinar Dr. Pierre Thibault will present a simple, new step to their existing workflow with the addition of a novel gas phase ion fractionation device to increase proteome coverage and confidence in global proteome profiling. This study will highlight the advantages of the Thermo Scientific FAIMS Pro device in quantitative proteomics using SILAC and TMT labelling to improve the accuracy, precision, and comprehensiveness of quantitative measurements.
Researchers, Lab technicians and Directors including:
Dr. Pierre Thibault, Professor, Department of Chemistry, Faculty of Arts and Sciences
Dr. Pierre Thibault is a renowned bioanalytical chemist specialized in mass spectrometry and proteomics with more than 25 years of experience as a principal investigator in academic, government and industry laboratories. Before joining IRIC in 2004, Dr. Thibault was a founding director at Caprion Pharmaceuticals (2001-2004) where he developed an innovative proteomics platform together with bioinformatic tools to identify and quantify proteins differentially expressed in cancer cells as part of immunotherapy programs in partnership with pharmaceutical companies. He was also a Senior Research Officer with the National Research Council of Canada’s Institute of Marine Biosciences in Halifax (1990-1996) and Institute of Biological Sciences in Ottawa (1996-2002). He pioneered the use of sensitive high-resolution separation methods and microfluidic devices coupled to mass spectrometry and their applications in protein chemistry and cell biology. His current research program in mass spectrometry-based proteomics provides a deeper understanding of molecular mechanisms and post-translational modifications, which regulate the function and translocation of proteins involved in immunity and signalling in cancer cells. His scientific achievements in this area have been recognized by numerous awards and distinctions including most recently the 2019 CSMS Fred Lossing award, 2018 ACFAS Urgel Archambault award and the 2017 Tony Pawson CNPN award. He authored more than 240 publications in scientific journals including Cell, Nature, and Nature medicine. He is editor of the journal Rapid Communications in Mass Spectrometry and Molecular & Cellular Proteomics.
* Required field